7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

TherapeuticsMD, Inc
(NASDAQ:TXMD) 

TXMD stock logo

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17-estradiol and progesterone for the treatment of moderate-to-severe vasomotor s...

Founded: 1907
Full Time Employees: 348
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends
TherapeuticsMD Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -245.16-129.44-13.72102217.72333.44449.16564.87
TherapeuticsMD Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0123.75247.5371.25495618.75742.5866.24
TherapeuticsMD Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -151.24-110.36-69.47-28.5912.2953.1894.06134.94
TherapeuticsMD Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -16.02-13.17-10.33-7.48-4.64-1.81.053.89
TherapeuticsMD Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -15.95-13.12-10.28-7.45-4.61-1.781.053.89
TherapeuticsMD Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.61.21.812.413.013.614.22
TherapeuticsMD P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.795.588.3711.1613.9516.7419.53
TherapeuticsMD (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -5.97-4.99-4-3.02-2.03-1.05-0.060.92
TherapeuticsMD P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.42-2.74-2.06-1.38-0.7-0.020.661.34
No extra charts and metrics for this ticker.